ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,000 | +40.0% | 14,024 | +75.3% | 0.00% | – |
| Q2 2023 | $30,000 | +57.9% | 7,998 | +38.5% | 0.00% | – |
| Q1 2023 | $19,000 | -63.5% | 5,774 | -45.9% | 0.00% | – |
| Q4 2022 | $52,000 | +100.0% | 10,664 | +135.1% | 0.00% | – |
| Q3 2022 | $26,000 | +73.3% | 4,536 | +123.6% | 0.00% | – |
| Q2 2022 | $15,000 | -63.4% | 2,029 | -63.6% | 0.00% | – |
| Q1 2022 | $41,000 | -59.0% | 5,568 | -50.5% | 0.00% | – |
| Q4 2021 | $100,000 | -65.5% | 11,249 | +36.4% | 0.00% | – |
| Q3 2021 | $290,000 | +118.0% | 8,247 | +33.9% | 0.00% | – |
| Q2 2021 | $133,000 | +121.7% | 6,157 | +530.2% | 0.00% | – |
| Q1 2021 | $60,000 | +300.0% | 977 | +169.9% | 0.00% | – |
| Q4 2020 | $15,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |